Login / Signup

Smartphone Apps for Managing Antithrombotic Therapy: Scoping Literature Review.

Friederike PrausKrzowski BartoszTabea WaltherChristian GratzkePaweł BalsamArkadiusz MiernikPhilippe Fabian Pohlmann
Published in: JMIR cardio (2022)
Throughout the evaluated data, patients from all age groups receiving antithrombotic drugs expressed the desire for a digital tool that could support their therapy management. In addition, physicians using mobile guideline-based apps may have contributed to decreased adverse event rates among their patients. In general, digital apps encompassing both user-friendly designs and scientific backgrounds may enhance the safety of antithrombotic therapies. However, our evaluation did not identify any apps that addressed all antithrombotic drugs in combination with perioperative stratification strategies. Currently, strict regulations for smartphone apps seem to negatively affect the development of new apps. Therefore, new legal policies for medical digital apps are urgently needed.
Keyphrases
  • atrial fibrillation
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • public health
  • stem cells
  • peritoneal dialysis
  • cardiac surgery
  • acute kidney injury
  • cell therapy
  • low cost
  • replacement therapy